Search

everythinglearnresearchcommunity

for

Search:↓

Collider bias can distort our understanding of COVID-19 risk and severity.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Sub3 is essential for fungus adherence but not for skin invasion.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.